​

Funding Round

Series D - Affectis Pharmaceuticals

Series D - Affectis Pharmaceuticals

Investment Firm

Overview

Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs.

Announced Date

Mar 22, 2010

Funding Type

Series D

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorLSP BioVentures
Participant InvestorEMBL Ventures
Participant InvestorKfW
Participant InvestorAescap Venture
Participant InvestorBayern Kapital

Round Details and Background

Affectis Pharmaceuticals raised $4465597 on 2010-03-22 in Series D

Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 01, 2003
Series A - Affectis Pharmaceuticals
1-undefined
Oct 24, 2006
Series C - Affectis Pharmaceuticals
1-15.1M
Oct 19, 2005
Series B - Affectis Pharmaceuticals
1-4.8M
Mar 22, 2010
Series D - Affectis Pharmaceuticals
5-4.5M

Recent Activity

There is no recent news or activity for this profile.